Samuel Wickline
Chief Tech/Sci/R&D Officer at ALTAMIRA THERAPEUTICS LTD.
Profile
Samuel A.
Wickline is the founder.
He founded Kereos, Inc. in 1999 and PixelEXX Systems, Inc. in 2007.
At Kereos, Inc., he held the title of Director.
At PixelEXX Systems, Inc., he currently holds the title of Director.
Dr. Wickline is also the founder of Trasir Therapeutics, Inc. Dr. Wickline's current job is Co-Director-Cardiovascular Division at Washington University School of Medicine.
He is also the Chief Scientific Adviser at Altamira Therapeutics Ltd.
since 2022 and a Professor-Cardiovascular Sciences at the University of South Florida since 2016.
Dr. Wickline's former job was Director at USF Health Morsani College of Medicine.
He was also a Professor at the University of Washington from 1980 to 2016.
Dr. Wickline obtained a doctorate degree from the University of Hawai'i at Hilo.
Samuel Wickline active positions
| Companies | Position | Start |
|---|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Chief Tech/Sci/R&D Officer | 01/06/2021 |
PixelEXX Systems, Inc.
 PixelEXX Systems, Inc. Miscellaneous Commercial ServicesCommercial Services PixelEXX Systems, Inc. manufactures semiconductor nanoarrays for molecular diagnostics and microscopy. The company was founded by Stuart Solin, Samuel A. Wickline, Kirk Wallace and Michael Hughes in 2007 and is headquartered in Chicago, IL. | Founder | 03/11/2009 |
| Washington University School of Medicine | Corporate Officer/Principal | - |
| University of South Florida | Corporate Officer/Principal | 01/11/2016 |
Former positions of Samuel Wickline
| Companies | Position | End |
|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | 01/01/2016 |
| USF Health Morsani College of Medicine | Director/Board Member | - |
Trasir Therapeutics, Inc.
 Trasir Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Altamira Therapeutics Ltd., Trasir Therapeutics, Inc. develops specialty pharmaceutical products. The company is based in Tampa, FL. The company was founded by Samuel A. Wickline. Trasir Therapeutics was acquired by Altamira Therapeutics Ltd. on June 03, 2021 for $4.32 million. | Founder | - |
Kereos, Inc.
 Kereos, Inc. Pharmaceuticals: MajorHealth Technology Kereos, Inc. develops and manufactures biotechnology products. The firm focuses on nanodroplet technology that allows delivery of a range of drug compounds to a target in the body for the treatment of diseases. The company was founded by Samuel A. Wickline and Gregory M. Lanza in 1999 and is headquartered in St. Louis, MO. | Founder | - |
Training of Samuel Wickline
| University of Hawai'i at Hilo | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Health Technology |
| Private companies | 3 |
|---|---|
Kereos, Inc.
Kereos, Inc. Pharmaceuticals: MajorHealth Technology Kereos, Inc. develops and manufactures biotechnology products. The firm focuses on nanodroplet technology that allows delivery of a range of drug compounds to a target in the body for the treatment of diseases. The company was founded by Samuel A. Wickline and Gregory M. Lanza in 1999 and is headquartered in St. Louis, MO. | Health Technology |
PixelEXX Systems, Inc.
PixelEXX Systems, Inc. Miscellaneous Commercial ServicesCommercial Services PixelEXX Systems, Inc. manufactures semiconductor nanoarrays for molecular diagnostics and microscopy. The company was founded by Stuart Solin, Samuel A. Wickline, Kirk Wallace and Michael Hughes in 2007 and is headquartered in Chicago, IL. | Commercial Services |
Trasir Therapeutics, Inc.
Trasir Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Altamira Therapeutics Ltd., Trasir Therapeutics, Inc. develops specialty pharmaceutical products. The company is based in Tampa, FL. The company was founded by Samuel A. Wickline. Trasir Therapeutics was acquired by Altamira Therapeutics Ltd. on June 03, 2021 for $4.32 million. | Health Technology |
- Stock Market
- Insiders
- Samuel Wickline
